Logo image of FBYD

FALCON'S BEYOND GLOBAL INC-A (FBYD) Stock Fundamental Analysis

USA - NASDAQ:FBYD - US3061211047 - Common Stock

14.99 USD
+1.52 (+11.28%)
Last: 9/19/2025, 8:02:36 PM
14.99 USD
0 (0%)
After Hours: 9/19/2025, 8:02:36 PM
Fundamental Rating

1

FBYD gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 81 industry peers in the Professional Services industry. FBYD has a bad profitability rating. Also its financial health evaluation is rather negative. FBYD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FBYD had negative earnings in the past year.
FBYD had a negative operating cash flow in the past year.
FBYD Yearly Net Income VS EBIT VS OCF VS FCFFBYD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

FBYD has a worse Return On Assets (-20.95%) than 83.95% of its industry peers.
Industry RankSector Rank
ROA -20.95%
ROE N/A
ROIC N/A
ROA(3y)-24.43%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FBYD Yearly ROA, ROE, ROICFBYD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 50 -50

1.3 Margins

The Gross Margin of FBYD (154.33%) is better than 100.00% of its industry peers.
FBYD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 154.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBYD Yearly Profit, Operating, Gross MarginsFBYD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

FBYD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FBYD has been reduced compared to 1 year ago.
The debt/assets ratio for FBYD is higher compared to a year ago.
FBYD Yearly Shares OutstandingFBYD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 50M 100M 150M
FBYD Yearly Total Debt VS Total AssetsFBYD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 3.13 indicates that FBYD is not in any danger for bankruptcy at the moment.
FBYD has a Altman-Z score (3.13) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 3.13
ROIC/WACCN/A
WACC8.76%
FBYD Yearly LT Debt VS Equity VS FCFFBYD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.03 indicates that FBYD may have some problems paying its short term obligations.
FBYD has a worse Current ratio (0.03) than 95.06% of its industry peers.
A Quick Ratio of 0.03 indicates that FBYD may have some problems paying its short term obligations.
The Quick ratio of FBYD (0.03) is worse than 95.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
FBYD Yearly Current Assets VS Current LiabilitesFBYD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for FBYD have decreased strongly by -13242.81% in the last year.
EPS 1Y (TTM)-13242.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18543.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBYD Yearly Revenue VS EstimatesFBYD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FBYD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FBYD Price Earnings VS Forward Price EarningsFBYD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBYD Per share dataFBYD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FBYD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FALCON'S BEYOND GLOBAL INC-A

NASDAQ:FBYD (9/19/2025, 8:02:36 PM)

After market: 14.99 0 (0%)

14.99

+1.52 (+11.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-19 2025-08-19
Earnings (Next)11-12 2025-11-12
Inst Owners1.09%
Inst Owner Change-6.81%
Ins Owners1.74%
Ins Owner Change-13.7%
Market Cap1.81B
AnalystsN/A
Price TargetN/A
Short Float %0.27%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 346.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.04
BVpS-0.51
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 154.33%
FCFM N/A
ROA(3y)-24.43%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 3.13
F-Score2
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13242.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18543.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-272.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3477.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3435.77%
OCF growth 3YN/A
OCF growth 5YN/A